Daré Bioscience, Inc. (DARE)
2.03
+0.17
(+9.14%)
USD |
NASDAQ |
Dec 10, 16:00
2.03
0.00 (0.00%)
After-Hours: 16:55
Daré Bioscience Total Assets (Quarterly): 30.75M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Omeros Corp. | 185.71M |
| GeoVax Labs, Inc. | 6.731M |
| Vistagen Therapeutics, Inc. | 80.93M |
| Editas Medicine, Inc. | 201.75M |
| Spero Therapeutics, Inc. | 54.17M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.89M |
| Shareholders Equity (Quarterly) | 2.858M |
| Debt to Equity Ratio | 2.856 |
| Current Ratio | 1.178 |
| Net Debt Paydown Yield | -1.64% |